Iterum Therapeutics (ITRM) Stock Chart & Stock Price History $0.72 -0.02 (-3.09%) Closing price 08/25/2025 03:58 PM EasternExtended Trading$0.72 +0.00 (+0.42%) As of 08/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Iterum Therapeutics Stock Price Performance The Iterum Therapeutics (ITRM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 38.38%, with a year-to-date return of -59.27%. In the past month, the stock has decreased 10.16%, reflecting recent market activity. As of the latest close, Iterum Therapeutics traded at $0.72 with a market cap of $32.20 million and volume of 635,176 shares. Five years ago, the stock traded at a split-adjusted price of $10.65, representing a 93.23% decrease over that period. At the time, it had a market cap of $14.71 million and a volume of 126,964 shares. Receive ITRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.87%1 Month Performance-10.16%3 Month Performance-22.62%Year-To-Date Performance-59.27%1 Year Performance-38.38%5 Year Performance-93.23% ITRM Stock Chart for Tuesday, August, 26, 2025 ITRM Chart by TradingView Iterum Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025$0.74$0.72-3.09%$0.75$0.71635,176 shs$32.20 million08/22/2025$0.75$0.74-0.80%$0.78$0.73623,818 shs$33.23 million08/21/2025$0.76$0.75-1.28%$0.77$0.71991,597 shs$33.50 million08/20/2025$0.83$0.76-8.56%$0.85$0.741.42 million shs$33.93 million08/19/2025$0.87$0.83-4.51%$0.90$0.81748,178 shs$37.10 million08/18/2025$0.86$0.87+0.80%$0.91$0.85673,199 shs$38.85 million08/15/2025$0.82$0.86+5.26%$0.87$0.83687,825 shs$38.55 million08/14/2025$0.82$0.82+0.42%$0.84$0.80776,885 shs$36.62 million08/13/2025$0.77$0.82+5.64%$0.86$0.811.39 million shs$36.47 million08/12/2025$0.71$0.77+8.23%$0.79$0.731.60 million shs$34.52 million Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025$0.71$0.71+0.45%$0.75$0.71763,863 shs$31.90 million08/08/2025$0.69$0.71+2.38%$0.76$0.70945,956 shs$31.75 million08/07/2025$0.70$0.69-0.79%$0.72$0.68716,101 shs$29.26 million08/06/2025$0.70$0.70+0.66%$0.72$0.661.19 million shs$29.49 million08/05/2025$0.71$0.70-2.58%$0.76$0.691.67 million shs$29.30 million08/04/2025$0.73$0.71-2.49%$0.78$0.683.25 million shs$30.07 million08/01/2025$0.73$0.73+0.11%$0.76$0.72496,436 shs$29.28 million07/31/2025$0.75$0.73-2.38%$0.79$0.72711,909 shs$29.25 million07/30/2025$0.75$0.75-0.13%$0.78$0.72902,739 shs$29.96 million07/29/2025$0.78$0.75-3.85%$0.80$0.74935,296 shs$30 million07/28/2025$0.80$0.78-2.80%$0.84$0.77719,080 shs$31.20 million07/25/2025$0.83$0.80-2.73%$0.84$0.80873,135 shs$32.10 million Related Companies BioHarvest Sciences Stock Price Chart Kyverna Therapeutics Stock Price Chart Theratechnologies Stock Price Chart Seres Therapeutics Stock Price Chart biote Stock Price Chart IO Biotech Stock Price Chart Molecular Partners Stock Price Chart Immuneering Stock Price Chart Genelux Stock Price Chart TuHURA Biosciences Stock Price Chart Receive ITRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ITRM) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Iterum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access